Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105507

Studies on the Epidemiology of Escherichia coli Infections. V. Factors Influencing Acquisition of Specific Serologic Groups

Richard H. Winterbauer, Marvin Turck, and Robert G. Petersdorf

Department of Medicine, University of Washington School of Medicine, and King County Hospital, Seattle, Wash.

†

Epidemic Intelligence Service Officer. Communicable Disease Center, U. S. Public Health Service, assigned to the University of Washington.

‡

Address requests for reprints to Dr. Marvin Turck, King County Hospital, Seattle, Wash. 98104.

*

Submitted for publication April 25, 1966; accepted September 15, 1966.

This work was supported in part by training grant AI-146-06 and grant AI-06311-02 from the National Institutes of Health, U. S. Public Health Service. Presented in part at the Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, October 17, 1965.

Find articles by Winterbauer, R. in: PubMed | Google Scholar

Department of Medicine, University of Washington School of Medicine, and King County Hospital, Seattle, Wash.

†

Epidemic Intelligence Service Officer. Communicable Disease Center, U. S. Public Health Service, assigned to the University of Washington.

‡

Address requests for reprints to Dr. Marvin Turck, King County Hospital, Seattle, Wash. 98104.

*

Submitted for publication April 25, 1966; accepted September 15, 1966.

This work was supported in part by training grant AI-146-06 and grant AI-06311-02 from the National Institutes of Health, U. S. Public Health Service. Presented in part at the Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, October 17, 1965.

Find articles by Turck, M. in: PubMed | Google Scholar

Department of Medicine, University of Washington School of Medicine, and King County Hospital, Seattle, Wash.

†

Epidemic Intelligence Service Officer. Communicable Disease Center, U. S. Public Health Service, assigned to the University of Washington.

‡

Address requests for reprints to Dr. Marvin Turck, King County Hospital, Seattle, Wash. 98104.

*

Submitted for publication April 25, 1966; accepted September 15, 1966.

This work was supported in part by training grant AI-146-06 and grant AI-06311-02 from the National Institutes of Health, U. S. Public Health Service. Presented in part at the Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, October 17, 1965.

Find articles by Petersdorf, R. in: PubMed | Google Scholar

Published January 1, 1967 - More info

Published in Volume 46, Issue 1 on January 1, 1967
J Clin Invest. 1967;46(1):21–29. https://doi.org/10.1172/JCI105507.
© 1967 The American Society for Clinical Investigation
Published January 1, 1967 - Version history
View PDF
Abstract

Stool carrier rates of Escherichia coli serogroups 4, 6, and 75 were determined on admission and discharge for 190 patients. Persons who were in the hospital 3 weeks or longer had an intestinal carrier rate of 46% compared to a rate of 28% in individuals who had no recent hospital contact. Treatment with broad spectrum antibiotics increased the susceptibility for acquisition of certain specific serologic groups. This was apparently not related to replacement of sensitive E. coli by drug-resistant forms. Studies were made to determine the environmental source for colonization of hospitalized patients and the risk of urinary infection in stool carriers of these strains. A survey of inanimate objects of medical and urological wards demonstrated infrequent isolation of 04, 06, and 075, indicating that extraintestinal foci were an unlikely source for hospital-acquired E. coli. Hemagglutination titers with determination of group-specific O antibody failed to demonstrate any deficiency in hospitalized patients who became colonized with certain coliforms. Similarly, no significant deficit in group-specific serum antibody was found in patients who were community carriers of E. coli 04, 06, or 075. Despite a high rate of acquisition of E. coli serogroups 4, 6, and 75 in the stools of hospitalized patients, only those patients undergoing urinary tract manipulation developed bacteriuria.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 21
page 21
icon of scanned page 22
page 22
icon of scanned page 23
page 23
icon of scanned page 24
page 24
icon of scanned page 25
page 25
icon of scanned page 26
page 26
icon of scanned page 27
page 27
icon of scanned page 28
page 28
icon of scanned page 29
page 29
Version history
  • Version 1 (January 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts